Clincosm LogoSign in Get a demo

Non-Hodgkin Lymphoma

Showing 76 - 100 of 213
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from

Recruiting
  • B-Cell Lymphoid Malignancies
  • +2 more
  • Hematopoietic Stem Cells from HLA-compatible Related
  • Hematopoietic Stem Cells from HLA Unrelated
  • Miami, Florida
    Miami Cancer Institute at Baptist Health of South Florida
May 5, 2022

B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma Trial in Worldwide (CTX110)

Recruiting
  • B-cell Malignancy
  • +3 more
  • CTX110
  • Los Angeles, California
  • +27 more
May 6, 2022

Non-Hodgkin Lymphoma, Multiple Myeloma Trial in New York ([68Ga]-Pentixafor)

Recruiting
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 4, 2022

Lymphoma, Multiple Myeloma, Non-Hodgkin Lymphoma Trial in New York (Isatuximab, Standard Procedures)

Recruiting
  • Lymphoma
  • +3 more
  • New York, New York
    Columbia University
Apr 27, 2022

Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in United States (PBCAR0191, Fludarabine, Cyclophosphamide)

Recruiting
  • Non-Hodgkin Lymphoma
  • B-cell Acute Lymphoblastic Leukemia
  • PBCAR0191
  • +2 more
  • Duarte, California
  • +9 more
Apr 18, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Radiation
  • +3 more
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 6, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022

Non-Hodgkin Lymphoma Trial in Switzerland (Copanlisib, Venetoclax)

Terminated
  • Non-Hodgkin Lymphoma
  • Basel, Switzerland
  • +5 more
Mar 18, 2022

Collecting and Storing Tissue Samples From Rare or Cutaneous

Active, not recruiting
  • Adult Immunoblastic Lymphoma
  • +12 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +129 more
Mar 23, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma Trial in United States (NKTR-255, NKTR-255 Q21, Rituximab)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Goodyear, Arizona
  • +16 more
Mar 18, 2022

Non-Hodgkin Lymphoma Trial in Saint Louis, Cleveland (Cyclophosphamide, Fludarabine, CAR-T Cells)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Saint Louis, Missouri
  • +1 more
Mar 10, 2022

Non-Hodgkin Lymphoma Trial in Santa Monica, Pittsburgh (IGN002)

Terminated
  • Non-Hodgkin Lymphoma
  • IGN002
  • Santa Monica, California
  • +1 more
Feb 23, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Survivors of Transplant, CREST Study

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Bioelectric Impedance Analysis
  • +7 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Mar 7, 2022

Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial in United States (Romiplostim)

Active, not recruiting
  • Multiple Myeloma
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Mar 7, 2022

Hodgkin Lymphoma, Non-hodgkin Lymphoma Trial in United States (AB-205)

Completed
  • Hodgkin Lymphoma
  • Non-hodgkin Lymphoma
  • AB-205
  • Duarte, California
  • +8 more
Mar 1, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical

Recruiting
  • Acute Myeloid Leukemia
  • +10 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Mar 1, 2022

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus

Active, not recruiting
Has Results
  • Acute Myelogenous Leukemia
  • +10 more
  • Atlanta, Georgia
  • +2 more
Feb 9, 2022

Breast Cancer, Colorectal Cancer, Endometrial Cancer Trial in Birmingham, Memphis (Adapting MultiPLe Behavior Interventions That

Recruiting
  • Breast Cancer
  • +8 more
  • Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health
  • +3 more
  • Birmingham, Alabama
  • +1 more
Feb 8, 2022

Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)

Terminated
  • Lymphoma
  • +15 more
  • Charlottesville, Virginia
    University of Virginia
Feb 8, 2022

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)

Completed
  • Chronic Lymphocytic Leukemia
  • Non-Hodgkin Lymphoma
  • Tucson, Arizona
  • +9 more
Feb 10, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +12 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +2 more
Feb 17, 2022

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • autologous or syngeneic PBTLs and EBV-CTLs
  • Houston, Texas
  • +1 more
Feb 6, 2022

Solid Tumor, Non-Hodgkin Lymphoma Trial in Shanghai, Hangzhou (Gentulizumab)

Recruiting
  • Solid Tumor
  • Non-Hodgkin Lymphoma
  • Shanghai, Shanghai, China
  • +1 more
Jan 21, 2022

Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

Active, not recruiting
  • Acute Lymphoid Leukemia (ALL)
  • +5 more
  • Hyperfractionated total body irradiation
  • +9 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022